Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol in Late-onset Pompe Disease
NCT01885936Phase 2Completed
- Sponsor
- Duke University
- Start
- Jun 2013
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Pompe disease comparing Albuterol with Placebo (2 arms). Primary endpoint: Number of Participants With Adverse Events at 52 weeks. Started Jun 2013; status: completed.
02
Drugs
salbutamol
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT01885936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01885936.